Blog: April 2025

How BioSkryb’s PTA is redefining single-cell genomics

Single-cell genomics has transformed our understanding of cellular diversity in both health and disease. Yet, a key technical challenge persists: how to amplify the minute amounts of DNA in a single cell without ...
Continue reading

Amoy Diagnostics: strengthening precision oncology through strategic partnership

Amoy Diagnostics (AmoyDx) and Almac Diagnostic Services have developed a partnership over the past five years, significantly advancing the field of precision oncology. This collaboration has led to the development and ...
Continue reading

Unlocking Precision: The importance of targeted drug delivery in drug discovery

Targeted delivery is especially vital for reducing off-target effects when developing treatments for complex diseases. Lipid nanoparticles (LNPs) offer a great solution for this.
Continue reading

Difficult biospecimen sourcing: Challenge? Accepted!

Here are some requests from our customers that have kept us on our toes recently, and how we met those requirements.
Continue reading